Scynexis (SCYX) Free Cash Flow Growth (1y) (2014 - 2026)
Scynexis (SCYX) Free Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 134.35% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.21% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -37.45% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 58.76% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 97.24% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 43.69% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 35.56% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | -98.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -98.60% |
| Mar 31, 2026 | -8.52% |
| Dec 31, 2025 | 285.74% |
| Sep 30, 2025 | -1,240.39% |
| Jun 30, 2025 | 30.99% |
| Mar 31, 2025 | -86.30% |
| Dec 31, 2024 | -28.08% |
| Sep 30, 2024 | -93.84% |
| Jun 30, 2024 | -114.60% |
| Mar 31, 2024 | 78.82% |
| Dec 31, 2023 | 66.08% |
| Sep 30, 2023 | 155.18% |
| Jun 30, 2023 | 500.40% |
| Mar 31, 2023 | -18.36% |
| Dec 31, 2022 | 8.93% |
| Sep 30, 2022 | -33.81% |
| Jun 30, 2022 | -56.96% |
| Mar 31, 2022 | -1,606.30% |
| Dec 31, 2021 | -51.15% |
| Sep 30, 2021 | -70.37% |